Your browser doesn't support javascript.
loading
Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents.
Lopez, Pio; Bravo, Lulu; Buntinx, Erik; Borja-Tabora, Charissa; Velasquez, Hector; Rodriquez, Edith Johana; Rodriguez, Camilo A; Carlos, Josefina; Montellano, May Emmeline B; Alberto, Edison R; Salvani-Bautista, Milagros; Huang, Yung; Hu, Branda; Li, Ping; Han, Htay Htay; Baccarini, Carmen; Smolenov, Igor.
Afiliação
  • Lopez P; Centro de Estudios en Infectología Pediátrica, Universidad Del Valle Clínica Imbanaco, Cali, Colombia.
  • Bravo L; College of Medicine, University of the Philippines Manila, Ermita, The Philippines.
  • Buntinx E; Anima Research Center, Alken, Belgium.
  • Borja-Tabora C; Asian Hospital and Medical Center, Muntinlupa, Philippines.
  • Velasquez H; Center of Attention in Medical Research (CAIMED), Bogotá, Colombia.
  • Rodriquez EJ; Center of Attention in Medical Research (CAIMED), Bogotá, Colombia.
  • Rodriguez CA; Policlínico Social del Norte, Bogotá, Colombia.
  • Carlos J; University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, The Philippines.
  • Montellano MEB; Far Eastern University Hospital - Nicanor Reyes Medical Foundation, Quezon City, The Philippines.
  • Alberto ER; Tropical Disease Foundation-HIMC, Cavite City, The Philippines.
  • Salvani-Bautista M; University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, The Philippines.
  • Huang Y; Clover Biopharmaceuticals, Boston, MA, USA.
  • Hu B; Clover Biopharmaceuticals, Boston, MA, USA.
  • Li P; Clover Biopharmaceuticals, Boston, MA, USA.
  • Han HH; Clover Biopharmaceuticals, Boston, MA, USA.
  • Baccarini C; Clover Biopharmaceuticals, Boston, MA, USA.
  • Smolenov I; Clover Biopharmaceuticals, Boston, MA, USA.
Hum Vaccin Immunother ; 19(1): 2206359, 2023 12 31.
Article em En | MEDLINE | ID: mdl-37226504

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Estados Unidos